» Articles » PMID: 33505869

Intensive Care Outcome of Left Main Stem Disease Surgery: A Single Center Three Years' Experience

Overview
Specialty Critical Care
Date 2021 Jan 28
PMID 33505869
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Left main coronary artery (LMCA) supplies more than 80% of the left ventricle, and significant disease of this artery carries a high mortality unless intervened surgically. However, the influence of coronary artery bypass grafting (CABG) surgery on patients with LMCA disease on morbidity intensive care unit (ICU) outcomes needs to be explored. However, the impact of CABG surgery on the morbidity of the ICU population with LMCA disease is worth exploring.

Aim: To determine whether LMCA disease is a definitive risk factor of prolonged ICU stay as a primary outcome and early morbidity within the ICU stay as secondary outcome.

Methods: Retrospective descriptive study with purposive sampling analyzing 399 patients who underwent isolated urgent or elective CABG. Patients were divided into 2 groups; those with LMCA disease as group 1 (75 patients) and those without LMCA disease as group 2 (324 patients). We correlated ICU outcome parameters including ICU length of stay, post-operative atrial fibrillation, acute kidney injury, re-exploration, perioperative myocardial infarction, post-operative bleeding in both groups.

Results: Patients with LMCA disease had a significantly higher prevalence of diabetes (43.3% 29%, = 0.001). However, we did not find a statistically significant difference with regards to ICU stay, or other morbidity and mortality outcome measures.

Conclusion: Post-operative performance of Patients with LMCA disease who underwent CABG were comparable to those without LMCA involvement. Diabetes was more prevalent in patients with LMCA disease. These findings may help in guiding decision making for future practice and stratifying the patients' care.

References
1.
Morice M, Serruys P, Kappetein A, Feldman T, Stahle E, Colombo A . Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation. 2014; 129(23):2388-94. DOI: 10.1161/CIRCULATIONAHA.113.006689. View

2.
Thiele H, Schuler G, Neumann F, Hausleiter J, Olbrich H, Schwarz B . Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J. 2012; 163(6):938-45. DOI: 10.1016/j.ahj.2012.03.012. View

3.
Omar A, Sudarsanan S, Hanoura S, Osman H, Sivadasan P, Shouman Y . Kinetics of Highly Sensitive Troponin T after Cardiac Surgery. Biomed Res Int. 2015; 2015:574546. PMC: 4619841. DOI: 10.1155/2015/574546. View

4.
Hou D, Yang F, Hou X . Clinical application of intra-aortic balloon counterpulsation in high-risk patients undergoing cardiac surgery. Perfusion. 2017; 33(3):178-184. DOI: 10.1177/0267659117734630. View

5.
Hammermeister K, Burchfiel C, Johnson R, Grover F . Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation. 1990; 82(5 Suppl):IV380-9. View